TEKADINE

This brand name is authorized in Nigeria.

Active ingredients

The drug TEKADINE contains one active pharmaceutical ingredient (API):

1	Cimetidine UNII 80061L1WGD - CIMETIDINE
	Cimetidine is a histamine H2-receptor antagonist which rapidly inhibits both basal and stimulated gastric secretion of acid and reduces pepsin output. It is a reversible, competitive antagonist, and is used as an anti-ulcer drug.
	Read more about Cimetidine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-1783	Tablet	TEKADINE 200 TABLETS TAB 200 mg 1x20	TEKADINE 200 TABLETS CIMETIDINE 200MG Each Tablets contains CIMETIDINE 200mg B4-1783 Drugs Imported Products 1x20 POM 1 26/05/2021 TEKA PHARMACEUTICALCOMPANY LTD, ,ZUNGERU ROAD, NOMANSLAND KANO KANO 7066430624 tekapharmaceuticalco@outlook.com JIANGXI XIER KANGTAI PHARM CO LTD., NORTH ZONE, HIGH, NEW TECHNOLOGY INDUSTRIAL ZONE, PINGIXIANG, CHINA, China	26/04/2023
B4-1784	Tablet	TEKADINE 400 TABLETS TAB 400 mg 1x20	TEKADINE 400 TABLETS CIMETIDINE 400MG Each Tablets contains CIMETIDINE 400 mg B4-1784 Drugs Imported Products 1x20 POM 1 21/05/2021 TEKA PHARMACEUTICALCOMPANY LTD, ,ZUNGERU ROAD, NOMANSLAND KANO KANO 7066430624 tekapharmaceuticalco@outlook.com JIANGXI XIER KANGTAI PHARM CO LTD., NORTH ZONE, HIGH, NEW TECHNOLOGY INDUSTRIAL ZONE, PINGIXIANG, CHINA, China	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A02BA01	Cimetidine	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BA H2-receptor antagonists
Discover more medicines within A02BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-1783, B4-1784